loading
Precedente Chiudi:
$0.3713
Aprire:
$0.3607
Volume 24 ore:
340.82K
Relative Volume:
0.25
Capitalizzazione di mercato:
$2.20M
Reddito:
-
Utile/perdita netta:
$-22.56M
Rapporto P/E:
-0.1832
EPS:
-1.93
Flusso di cassa netto:
$-16.12M
1 W Prestazione:
-10.10%
1M Prestazione:
-73.21%
6M Prestazione:
-84.29%
1 anno Prestazione:
+30.47%
Intervallo 1D:
Value
$0.3241
$0.377
Intervallo di 1 settimana:
Value
$0.3241
$0.3933
Portata 52W:
Value
$0.231
$4.3785

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
Nome
Cyclacel Pharmaceuticals Inc
Name
Telefono
908-517-7330
Name
Indirizzo
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
Dipendente
12
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
CYCC's Discussions on Twitter

Confronta CYCC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
CYCC 0.3585 2.20M 0 -22.56M -16.12M -1.93
VRTX 449.11 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.63 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 597.08 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.44 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.09 24.89B 3.30B -501.07M 1.03B 11.54

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-07-18 Ripresa Oppenheimer Outperform
2020-04-27 Ripresa ROTH Capital Buy
2018-09-07 Iniziato Ladenburg Thalmann Buy
2015-10-16 Iniziato H.C. Wainwright Buy
2010-02-04 Iniziato Roth Capital Buy
2009-10-28 Iniziato Merriman Buy
2008-08-12 Iniziato Piper Jaffray Buy
2008-03-12 Reiterato Cantor Fitzgerald Buy
2008-03-12 Reiterato Collins Stewart Buy
2008-03-12 Reiterato Needham & Co Buy
2007-11-27 Reiterato Cantor Fitzgerald Buy
2007-08-10 Reiterato Cantor Fitzgerald Buy
2007-06-04 Reiterato Needham & Co Buy
2007-04-23 Iniziato Lazard Capital Buy
2007-04-10 Iniziato Cantor Fitzgerald Buy
Mostra tutto

Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie

pulisher
01:08 AM

Cyclacel stock plunges to 52-week low of $0.32 amid market challenges - Investing.com

01:08 AM
pulisher
Nov 18, 2024

Cyclacel Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Armistice Capital, LLC Increases Stake in Cyclacel Pharmaceutica - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

Cyclacel stock plunges to 52-week low of $0.37 amid market challenges - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise Deal at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Cyclacel Faces Delisting Risk Despite 67% Lower Q3 Loss; Cash Concerns Mount | CYCC Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 09, 2024

(CYCCP) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 09, 2024
pulisher
Nov 08, 2024

A Data-Based Look At Cyclacel Pharmaceuticals Inc (CYCC) - Stocks Register

Nov 08, 2024
pulisher
Nov 04, 2024

Cyclacel stock plunges to 52-week low at $0.6 amid market challenges - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Cyclacel stock plunges to 52-week low at $0.74 amid market challenges - Investing.com India

Oct 28, 2024
pulisher
Oct 24, 2024

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - The Manila Times

Oct 24, 2024
pulisher
Oct 23, 2024

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - ForexTV.com

Oct 23, 2024
pulisher
Oct 23, 2024

Nasopharyngeal Cancer Market Report: Growth Forecast and Key - openPR

Oct 23, 2024
pulisher
Oct 22, 2024

Sangamo Therapeutics, Cyclacel Pharma, GE Aerospace: 3 Stocks Retailers Are Most Bullish Tuesday Afternoon - Barchart

Oct 22, 2024
pulisher
Oct 21, 2024

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register

Oct 21, 2024
pulisher
Oct 13, 2024

CYCCPCyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock Latest Stock News & Market Updates - StockTitan

Oct 13, 2024
pulisher
Oct 12, 2024

Cyclacel Pharmaceuticals (CYCC) Price Target Increased by 11.56% to 13.94 - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Cyclacel stock plunges to 52-week low, touches $0.8 By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 09, 2024

Cyclacel stock plunges to 52-week low, touches $0.8 - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

CYCCCyclacel Pharmaceuticals, Inc Latest Stock News & Market Updates - StockTitan

Oct 09, 2024
pulisher
Oct 09, 2024

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - The Manila Times

Oct 09, 2024
pulisher
Oct 01, 2024

Cyclacel stock plunges to 52-week low at $0.95 amid market challenges - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Cyclacel stock plunges to 52-week low at $0.95 amid market challenges By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Sep 25, 2024

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - ForexTV.com

Sep 25, 2024
pulisher
Sep 16, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

(CYCCP) Trading Report - Stock Traders Daily

Sep 16, 2024
pulisher
Sep 12, 2024

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Sep 12, 2024
pulisher
Sep 06, 2024

Cyclacel halts dividend on preferred stock - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

Cyclacel halts dividend on preferred stock By Investing.com - Investing.com Canada

Sep 06, 2024
pulisher
Sep 04, 2024

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 03, 2024

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - ForexTV.com

Sep 03, 2024
pulisher
Sep 03, 2024

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Benzinga

Sep 03, 2024

Cyclacel Pharmaceuticals Inc Azioni (CYCC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):